Cargando…
In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons
Purpose: Drug coated balloons (DCB) are continually improving due to advances in coating techniques and more effective excipients. Paclitaxel, the current drug choice of DCB, is a microtubule-stabilizing chemotherapeutic agent that inhibits smooth muscle cell proliferation. Excipients work to promot...
Autores principales: | Turner, Emily, Erwin, Megan, Atigh, Marzieh, Christians, Uwe, Saul, Justin M., Yazdani, Saami K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078047/ https://www.ncbi.nlm.nih.gov/pubmed/30104972 http://dx.doi.org/10.3389/fphar.2018.00808 |
Ejemplares similares
-
Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons
por: Goel, Emily, et al.
Publicado: (2020) -
The Development of an ex vivo Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices
por: Cooper, Kathryn, et al.
Publicado: (2021) -
Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease
por: Atigh, Marzieh K., et al.
Publicado: (2021) -
Pre-Clinical Investigation of Liquid Paclitaxel for Local Drug Delivery: A Pilot Study
por: Cawthon, Claire V., et al.
Publicado: (2020) -
Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons
por: Villar-Matamoros, Estefanny, et al.
Publicado: (2022)